Literature DB >> 19616294

Effect of cryopreservation by slow cooling and vitrification on viral contamination of IVF embryos experimentally exposed to bovine viral diarrhea virus and bovine herpesvirus-1.

A Bielanski1, A Lalonde.   

Abstract

The objective was to determine the effect of cryopreservation by conventional slow controlled cooling (0.5 degrees C/min) and by vitrification on the presence of bovine viral diarrhea virus (BVDV) and bovine herpesvirus-1 (BHV-1) infectivity associated with frozen-thawed Day 7 bovine embryos. In this study, Day 7 embryos generated by in vitro fertilization (IVF) were exposed in vitro for 1.5h to BVDV (N=393) and BHV-1 (N=242) and subsequently tested before and after cryopreservation for the presence of infectivity. Exposure of embryos to viral agents resulted in 72% of them infected prior to cryopreservation. Stepwise exposure of embryos to cryoprotectants, as well as their removal, substantially reduced the proportion of contaminated embryos (46% vs. 72%, P<0.05). Overall, both freezing methods reduced the percentage of infectious embryos compared with that of embryos similarly exposed to viruses but not cryopreserved (31% vs. 72%, respectively; P<0.001). The percentage of embryos with infectious viruses was not significantly higher after vitrification than after slow cooling (38% vs. 22%). In addition, after cryopreservation, a higher percentage (P<0.002) of embryos exposed to BHV-1 (42%) remained infectious than did embryos exposed to BVDV (24%). In conclusion, cryopreservation reduced the proportion of infected embryos but did not render all of them free from infectious pathogens.

Entities:  

Mesh:

Year:  2009        PMID: 19616294     DOI: 10.1016/j.theriogenology.2009.06.010

Source DB:  PubMed          Journal:  Theriogenology        ISSN: 0093-691X            Impact factor:   2.740


  1 in total

1.  A chemically defined medium for rabbit embryo cryopreservation.

Authors:  Pierre Bruyère; Anne Baudot; Thierry Joly; Loris Commin; Elodie Pillet; Pierre Guérin; Gérard Louis; Anne Josson-Schramme; Samuel Buff
Journal:  PLoS One       Date:  2013-08-20       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.